2025-12-22 - Analysis Report
Okay, let's break down this analysis of Procter & Gamble (PG).

**0) Overview**

*   **Ticker:** PG
*   **Company Name:** Procter & Gamble Co
*   **Overview:** Procter & Gamble is a multinational consumer goods corporation focused on providing branded consumer packaged goods.

**1) Return Rate Comparison**

*   **PG Cumulative Return:** 26.13%
*   **VOO (S&P 500) Cumulative Return:** 100.88%
*   **Divergence:** -74.75
*   **Relative Divergence:** 5.3

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the analyzed period. The divergence is substantial (-74.75%), indicating a large gap in cumulative returns.  The relative divergence of 5.3 suggests the current divergence is near the lower end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
|------------|---------|---------|--------|-------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%  | 0.0   | 215.0  |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%  | 0.1   | 215.1  |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%   | 0.3   | 292.3  |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%   | 0.4   | 325.7  |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%  | 0.5   | 382.9  |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%  | 0.6   | 354.7  |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%  | 0.4   | 343.0  |
| 2022-2024  | 9.0%    | 79.4%   | -12.0% | 0.4   | 392.4  |
| 2023-2025  | -18.0%  | 80.1%   | -83.0% | 0.1   | 338.1  |

**Analysis:**
* **CAGR:** The Compound Annual Growth Rate (CAGR) shows varying performance across different periods. The most recent period (2023-2025) indicates a significant decline (-18.0%).
* **MDD:** The Maximum Drawdown (MDD) is quite high, especially in recent periods, indicating significant potential losses from peak to trough.
* **Alpha:**  Alpha measures the stock's performance relative to a benchmark (presumably the market).  Negative alpha values indicate underperformance.  The recent period (2023-2025) shows a very large negative alpha (-83.0%), demonstrating substantial underperformance.
* **Beta:** Beta measures the stock's volatility relative to the market. A beta around 0.4 suggests PG is less volatile than the overall market.
* **Cap(B):** Shows the changing market cap (in Billions).

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 144.46
*   **Previous Close:** 145.52
*   **Change:** -0.73
*   **5-day SMA:** 145.63
*   **20-day SMA:** 144.91
*   **60-day SMA:** 148.06

**Analysis:** The stock price has declined slightly in the very recent period. The 5-day SMA is above the 20-day SMA, which suggests a short-term upward trend. However, the 60-day SMA is significantly higher than both, indicating that the longer-term trend is still downward.

**3) Indicators**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 47.18 (Neutral)
*   **PPO:** 0.33
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.0 (+): 단기상승 (Short-term rise)
*   **Expected Return (%):** -0.5

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is close to 50, suggesting neither overbought nor oversold conditions.
*   The PPO is slightly above zero.
*   The hybrid signal is positive.
*   The recent increase in divergence suggests a short-term upward trend.
*   The expected return is slightly negative (-0.5%), indicating potential underperformance compared to the S&P 500 in the long term.

**4) Recent News & Significant Events**

*   Multiple articles discuss PG's historical performance and potential investment strategies ("How Good Has PG Stock Actually Been?").
*   One article notes a recent decline in PG stock ("Procter & Gamble (PG) stock sinks as market gains").
*   Another provides a week-ahead outlook, including analyst calls and factors that could influence the stock ("Procter & Gamble Stock (NYSE: PG) Week-Ahead Outlook...").
*   Jim Cramer identified PG as a favorite portfolio stock.
*   One article compares PG to Colgate-Palmolive as an investment ("Buy PG Stock Over Colgate-Palmolive?").

**Analysis:** The news is mixed. While some articles highlight the stock as a potentially stable pick, others point out underperformance relative to the market and recent declines. The analyst outlook is important to consider.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.92 (~Buy)
*   **Opinions:** 22 analysts
*   **Target Price (avg/high/low):** 168.95 / 186.00 / 148.00

**Analysis:** Analysts, on average, have a "Buy" rating for PG and expect price appreciation based on the average target price ($168.95), which is significantly higher than the current price ($144.46).

**5) Recent Earnings Analysis**

| 날짜         | EPS    | 매출       |
|--------------|--------|------------|
| 2025-10-24   | 2.00   | 22.39 B$   |
| 2025-04-24   | 1.58   | 19.78 B$   |
| 2025-01-22   | 1.94   | 21.88 B$   |
| 2024-10-18   | 1.65   | 21.74 B$   |
| 2025-10-24   | 1.65   | 21.74 B$   |

**Analysis:** Revenue has fluctuated. Recent EPS growth looks favorable.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-09-30   | $22.39B     | 51.37%        |
| 2025-06-30   | $20.89B     | 49.11%        |
| 2025-03-31   | $19.78B     | 50.98%        |
| 2024-12-31   | $21.88B     | 52.39%        |
| 2024-09-30   | $21.74B     | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE   |
|--------------|-------------|-------|
| 2025-09-30   | $53.27B     | 8.92% |
| 2025-06-30   | $52.01B     | 6.95% |
| 2025-03-31   | $52.27B     | 7.21% |
| 2024-12-31   | $51.17B     | 9.05% |
| 2024-09-30   | $51.84B     | 7.64% |

**Analysis:** Revenue shows some fluctuation, and profit margins remain consistently high, indicating strong profitability. Equity has been generally increasing.  ROE also fluctuates, reflecting profitability on shareholder equity.

**7) Comprehensive Analysis**

*   **Underperformance:** PG has significantly underperformed the S&P 500 over the period, as highlighted by the large divergence in cumulative returns.
*   **Mixed Signals:** While recent earnings data and analyst consensus are positive, other indicators and news headlines paint a mixed picture.
*   **Volatility:** While less volatile than the market (low Beta), PG has experienced significant maximum drawdowns in recent periods.
*   **Valuation:** The current stock price is below the average analyst target price, suggesting potential upside.
*   **Financial Health:** PG's financials are generally strong, with consistently high profit margins and increasing equity.
*   **Recent Short-Term Rise:**  There's evidence of a recent short-term upward trend, but it's important to see if this momentum can be sustained.

**Conclusion:**

PG presents a complex investment picture. While its financial health is solid and analysts see potential upside, its recent underperformance compared to the broader market is a concern. The decision to invest in PG depends on an investor's risk tolerance, investment horizon, and belief in the company's ability to turn around its performance.  Consider the negative expected return of -0.5%. The positive analyst ratings and recent short-term rise provide some counterpoints, but further due diligence is warranted.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.